First published

Long Term: Entegris

Explore this signal

Long Term at a glance

Short reader summary

AI chips may create a second materials market in microscopic cleaning and heat-management consumables, but partnerships must become paid production orders.

Exact asset or item

Entegris

Asset type

Listed investment

Reference price

147.41

Currency code

USD

Price observed at

2026-11-13T16:00:00-05:00

What this number represents

Tracking price

What remains unproven

Historical tracking close, not a purchase or current executable quote. New plant, development partnerships and management targets do not establish paid production orders or future returns.

Exact asset or item

Exact asset or item

Entegris

Asset type

Listed investment

Ticker

ENTG

Exchange

NASDAQ

How to identify this exact asset

NASDAQ: ENTG common listed equity; United States / USD. Source dossier: 15 November 2026, 16:55 SGT. Main horizon: 3 years; RESEARCH WATCH.

Price and what it means

Entry or reference price

147.41

Currency code

USD

Price observed at

2026-11-13T16:00:00-05:00

What this number represents

Tracking price

Price evidence status

Verified

Price source

9. ENTG historical closing price

Publisher: Stock Analysis

Reading access: partial

published date precision: day

retrieved date precision: day

Source publication date 2026-11-13

Source retrieval date 2026-11-16

Matching price source ID

ENTG-S9

Purchase, sale and realised profit

Permanent original reference: USD 147.41 / Friday 13 November 2026, 16:00 EST / Stock Analysis historical closing-price page (URL as final source). This stays frozen for future corrections. Latest checked price: same 13 November historical close; no newer US session by this Sunday cutoff. Price change since original entry: 0.00 USD at this same reference observation only, NOT a trading gain; no new independent current executable price. Estimated result after costs: not assessable (zero executed shares; brokerage, spreads, FX and taxes are unknown). Actually sold: NO (no purchase was made). Forecast status: NOT YET DUE / UNRESOLVED. Next review: 15 May 2027; earlier trigger on next published company quarterly release. Preserve this baseline even if subsequent results contradict the thesis.

The developments we connected

Separate development

  1. What changed

    Q3 financial results

    Date of the development

    Evidence status

    Observed

    What the evidence shows

    Q3 sales around USD 1,005.7 million; one-off tariff items disclosed.

    Source IDs

    • ENTG-S1
  2. What changed

    Thermal materials expansion

    Date of the development

    Evidence status

    Observed

    What the evidence shows

    Advanced Abrasives acquisition completed; Taiwan SiC line planned; Element Six development partnership.

    Source IDs

    • ENTG-S4
  3. What changed

    Kioxia partnership

    Date of the development

    Evidence status

    Observed

    What the evidence shows

    Future-memory materials development, no reported sales volume.

    Source IDs

    • ENTG-S5
  4. What changed

    Long-term targets

    Date of the development

    Evidence status

    Observed

    What the evidence shows

    Management forecasts, not realised earnings.

    Source IDs

    • ENTG-S6

Emerging insight

REPORT A (29 October, higher reported semiconductor materials sales) -> REPORT B (3 November, completed diamond-abrasive purchase and planned Taiwan SiC line) -> REPORT C (5 November, Kioxia joint development of future memory process materials). REPORT D (9 November, long-term targets) is an aspiration. Hidden link: greater chip density requires cleaner surfaces AND better heat transfer. Materials suppliers could sell consumables each production cycle, rather than only one-time equipment, but customer qualification and margins decide economics.

How this exact asset could benefit

Beneficiary: Entegris from high-purity materials, filtration, slurries, abrasives, and potentially thermal-management materials. Proven: historical sales, acquisition completion and existing materials business. Unproven: Taiwanese new-line production, volume orders from Kioxia, commercial diamond cooling revenue, or achievement of management long-term margin goals. A lab partnership is not a customer order.

Who could benefit

  1. Who

    Entegris

    How they could benefit

    Beneficiary: Entegris from high-purity materials, filtration, slurries, abrasives, and potentially thermal-management materials. Proven: historical sales, acquisition completion and existing materials business. Unproven: Taiwanese new-line production, volume orders from Kioxia, commercial diamond cooling revenue, or achievement of management long-term margin goals. A lab partnership is not a customer order.

    Evidence status

    Still unproven

What we observed

30 April 2026: Entegris Q1 sales were about USD 811.9 million. 4 August: Q2 sales around USD 883.2 million. 29 October: Q3 sales around USD 1,005.7 million, and the firm identified one-off tariff-related items. 3 November: Entegris reported COMPLETING the Advanced Abrasives acquisition and PLANNING a SiC manufacturing line in Taiwan, plus a diamond-related development partnership with Element Six. 5 November: it expanded a materials development partnership with Japanese Kioxia for future memory; no sales volume was reported. 9 November: management presented long-term financial targets, which are forecasts, not realised earnings.

What remains unproven

Beneficiary: Entegris from high-purity materials, filtration, slurries, abrasives, and potentially thermal-management materials. Proven: historical sales, acquisition completion and existing materials business. Unproven: Taiwanese new-line production, volume orders from Kioxia, commercial diamond cooling revenue, or achievement of management long-term margin goals. A lab partnership is not a customer order.

What to check before acting

Entry conditions

Separate the 3 November acquisition that closed from plant investment that is planned, and the Kioxia partnership that is developmental. Compare cash generated from operations with capital spending in coming filings. Read management targets as hypotheses.

Possible upside

Newly qualified materials recur through high-volume chip fabrication and support higher cash margins.

Possible downside

R&D and Taiwan line consume cash without profitable commercial qualification; semiconductor cycle reverses.

Price or return range method

Downside: R&D and Taiwan line consume cash without profitable commercial qualification; semiconductor cycle reverses. Base: existing consumables grow but new thermal materials remain small. Upside: newly qualified materials recur through high-volume chip fabrication and support higher cash margins. Numeric future share-price range not estimated; company targets are not a verified outcome or valuation model.

Costs and fees

Spreads, custody, FX and taxes; R&D, capex, qualification and integration costs can affect outcomes.

How hard it may be to sell

Share sale via NASDAQ is possible at a market price, subject to spreads, custody, FX and taxes.

Key risks

Silicon cycles, customers shifting processes, materials qualification failures, Taiwan geopolitical/supply-chain disruption and high R&D spend. Alternative explanation: revenue growth comes from a semiconductor up-cycle and acquisitions rather than a lasting new materials advantage. Disproof: no disclosed commercial qualification or paid orders from the new SiC/diamond line by end 2028, AND core gross margin remains under 45% in two consecutive reported quarters. Share sale via NASDAQ is possible at a market price, subject to spreads, custody, FX and taxes.

What an ordinary reader can do next

Separate the 3 November acquisition that closed from plant investment that is planned, and the Kioxia partnership that is developmental. Compare cash generated from operations with capital spending in coming filings. Read management targets as hypotheses. Next near-term verification: the next Entegris quarterly results (date unconfirmed). Specific new-materials catalyst: first publicly disclosed paid production qualification/order and Taiwan line start, neither date confirmed.

Original forecast record

Original forecast in full

Long Term: Entegris

Category: Shares

Exact asset: NASDAQ: ENTG common listed equity

Country and currency: United States / USD

Published: 15 November 2026, 16:55 SGT

Information cutoff: 15 November 2026, 16:55 SGT

Main time horizon: 3 years

Current position: RESEARCH WATCH

Publication clarification, 16 November 2026 (SGT): The source's Published timestamp above is the dossier issue time, not this website article's first-publication time.

The opportunity in one sentence

AI chips may create a second materials market in microscopic cleaning and heat-management consumables, but partnerships must become paid production orders.

Entry price and date

Reference entry price: USD 147.41 per share; price observed Friday 13 November 2026 at 16:00 EST (Saturday 14 November 05:00 SGT), Stock Analysis history (underlying reported S&P Global Market Intelligence market data). Type of price: historical closing market quote, not broker order quote. Availability: listed common stock generally broker-accessible where legally allowed. Entry note: TRACKING PRICE ONLY, NOT AN ACTUAL PURCHASE.

What changed?

30 April 2026: Entegris Q1 sales were about USD 811.9 million. 4 August: Q2 sales around USD 883.2 million. 29 October: Q3 sales around USD 1,005.7 million, and the firm identified one-off tariff-related items. 3 November: Entegris reported COMPLETING the Advanced Abrasives acquisition and PLANNING a SiC manufacturing line in Taiwan, plus a diamond-related development partnership with Element Six. 5 November: it expanded a materials development partnership with Japanese Kioxia for future memory; no sales volume was reported. 9 November: management presented long-term financial targets, which are forecasts, not realised earnings.

Reported quarterly sales, not new-materials ordersUS$ million; reported quarterly actuals
Horizontal scale 0 to 1200Ticks 0 · 300 · 600 · 900 · 1200
View chart values
Reported quarterly sales, not new-materials orders
QuarterSales (US$ million)
Q1 2026811.9
Q2 2026883.2
Q3 20261005.7
Company-wide sales do not establish revenue from the planned Taiwan line or developmental partnerships. Tariff recovery is a separate cost adjustment, not sales.

The connection most people may miss

REPORT A (29 October, higher reported semiconductor materials sales) -> REPORT B (3 November, completed diamond-abrasive purchase and planned Taiwan SiC line) -> REPORT C (5 November, Kioxia joint development of future memory process materials). REPORT D (9 November, long-term targets) is an aspiration. Hidden link: greater chip density requires cleaner surfaces AND better heat transfer. Materials suppliers could sell consumables each production cycle, rather than only one-time equipment, but customer qualification and margins decide economics.

Four announcements, four different evidence states
  • Advanced AbrasivesAcquisition completed
  • Taiwan SiC linePlanned, not proven in production
  • Element Six / KioxiaDevelopment collaboration, not verified paid production volumes
  • Long-term financial targetsManagement forecasts, not realised earnings
None of the latter three states is interchangeable with delivered products, customer cash or shareholder returns.

How this could make money

Beneficiary: Entegris from high-purity materials, filtration, slurries, abrasives, and potentially thermal-management materials. Proven: historical sales, acquisition completion and existing materials business. Unproven: Taiwanese new-line production, volume orders from Kioxia, commercial diamond cooling revenue, or achievement of management long-term margin goals. A lab partnership is not a customer order.

Why the entry price matters

USD 147.41 is a Friday market-close reference. Compare diluted free cash per share and nonrecurring tariff refunds separately from operating profit. A long-term target of high margin growth is a sensitivity assumption, not a valuation input that has already happened. Check debt after acquisition, capex for the planned Taiwan plant, IP risks and customer concentration.

Time-horizon forecast

Time-horizon forecast
Time-horizon forecast
HorizonReview dateWhat we expect or need to seeWhat would challenge it
6 months15 May 2027Updates on Taiwan plant budget and pilot qualificationNo capex schedule or customer milestone
1 year15 Nov 2027Quarterly process-materials margin and paid customer qualificationOne-off price/margin bump, no new orders
2 years15 Nov 2028Commercial production order for SiC/diamond and FCF after capexNo paid order and gross margin below 45% two quarters
3 years15 Nov 2029Repeat customer consumables, Kioxia project commercial statusPartnership remains lab only
4 years15 Nov 2030Consistent cash per share after R&D costsSales gain but free cash disappoints
5 years15 Nov 2031Demand sustained through memory cycles and political riskNot enough evidence of durable advantage
Original source forecast,15 November 2026,16:55 SGT. These are tests, not achieved outcomes.
Sources
  • OTR Entegris source dossier · 15 November 2026,16:55 SGT

Possible price outcomes

Downside: R&D and Taiwan line consume cash without profitable commercial qualification; semiconductor cycle reverses. Base: existing consumables grow but new thermal materials remain small. Upside: newly qualified materials recur through high-volume chip fabrication and support higher cash margins. Numeric future share-price range not estimated; company targets are not a verified outcome or valuation model.

What could go wrong?

Silicon cycles, customers shifting processes, materials qualification failures, Taiwan geopolitical/supply-chain disruption and high R&D spend. Alternative explanation: revenue growth comes from a semiconductor up-cycle and acquisitions rather than a lasting new materials advantage. Disproof: no disclosed commercial qualification or paid orders from the new SiC/diamond line by end 2028, AND core gross margin remains under 45% in two consecutive reported quarters. Share sale via NASDAQ is possible at a market price, subject to spreads, custody, FX and taxes.

What an ordinary person can do

Separate the 3 November acquisition that closed from plant investment that is planned, and the Kioxia partnership that is developmental. Compare cash generated from operations with capital spending in coming filings. Read management targets as hypotheses.

What happens next?

Next near-term verification: the next Entegris quarterly results (date unconfirmed). Specific new-materials catalyst: first publicly disclosed paid production qualification/order and Taiwan line start, neither date confirmed.

OTR tracking record

Permanent original reference: USD 147.41 / Friday 13 November 2026, 16:00 EST / Stock Analysis historical closing-price page (URL as final source). This stays frozen for future corrections. Latest checked price: same 13 November historical close; no newer US session by this Sunday cutoff. Price change since original entry: 0.00 USD at this same reference observation only, NOT a trading gain; no new independent current executable price. Estimated result after costs: not assessable (zero executed shares; brokerage, spreads, FX and taxes are unknown). Actually sold: NO (no purchase was made). Forecast status: NOT YET DUE / UNRESOLVED. Next review: 15 May 2027; earlier trigger on next published company quarterly release. Preserve this baseline even if subsequent results contradict the thesis.

Publishing verification

16 November 2026 (SGT). All nine source links reopened successfully. The USD 8.3 million Q3 tariff refund is a nonrecurring recovery of earlier cost of goods sold, not sales; it was excluded from non-GAAP results. Q3 GAAP gross margin was 49.7%, while adjusted gross margin was 48.9%. These observations do not establish that the source's two-quarter 45% disproof condition has occurred. The Advanced Abrasives acquisition was completed; the Taiwan SiC line remains planned, Element Six and Kioxia activities remain developmental, and 9 November targets remain management forecasts. No paid new-materials production volume was established. The frozen USD 147.41 regular-session close remains historical; the separate USD 144.54 after-hours quote on 13 November at 19:58 EST (14 November 08:58 SGT) does not replace it. Entry price unavailable: no current executable quote was obtained. No supported terminal multiple, post-investment cash-flow forecast or numerical multi-year price target is established. The source's future 'core gross margin' test does not specify GAAP or adjusted basis; future reviews must disclose and compare a consistent basis.

Original forecast date and time

2026-11-15T16:55:00+08:00

Forecasts and review dates

6 months

Review date

2027-05-15

Original forecast

Updates on Taiwan plant budget and pilot qualification

What to measure

Updates on Taiwan plant budget and pilot qualification

What must happen

Updates on Taiwan plant budget and pilot qualification

What would challenge the forecast

No capex schedule or customer milestone

Current outcome

Not yet due

1 year

Review date

2027-11-15

Original forecast

Quarterly process-materials margin and paid customer qualification

What to measure

Quarterly process-materials margin and paid customer qualification

What must happen

Quarterly process-materials margin and paid customer qualification

What would challenge the forecast

One-off price/margin bump, no new orders

Current outcome

Not yet due

2 years

Review date

2028-11-15

Original forecast

Commercial production order for SiC/diamond and FCF after capex

What to measure

Commercial production order for SiC/diamond and FCF after capex

What must happen

Commercial production order for SiC/diamond and FCF after capex

What would challenge the forecast

No paid order and gross margin below 45% two quarters

Current outcome

Not yet due

3 years

Review date

2029-11-15

Original forecast

Repeat customer consumables, Kioxia project commercial status

What to measure

Repeat customer consumables, Kioxia project commercial status

What must happen

Repeat customer consumables, Kioxia project commercial status

What would challenge the forecast

Partnership remains lab only

Current outcome

Not yet due

4 years

Review date

2030-11-15

Original forecast

Consistent cash per share after R&D costs

What to measure

Consistent cash per share after R&D costs

What must happen

Consistent cash per share after R&D costs

What would challenge the forecast

Sales gain but free cash disappoints

Current outcome

Not yet due

5 years

Review date

2031-11-15

Original forecast

Demand sustained through memory cycles and political risk

What to measure

Demand sustained through memory cycles and political risk

What must happen

Demand sustained through memory cycles and political risk

What would challenge the forecast

Not enough evidence of durable advantage

Current outcome

Not yet due

Sources

Dated source

  1. Source ID

    ENTG-S1

    What this source supports

    Supports: Q3 sales, profits and adjustment detail. Reviewed: 15 November 2026, 16:55 SGT (edition-level source review checkpoint; HTTP completion clocks unavailable). Access: Opened/checked through web; date of HTTP retrieval not independently provided.

  2. Source ID

    ENTG-S2

    What this source supports

    Supports: Earlier quarterly sales trend. Reviewed: 15 November 2026, 16:55 SGT (edition-level source review checkpoint; HTTP completion clocks unavailable). Access: Opened/checked through web; date of HTTP retrieval not independently provided.

  3. Source ID

    ENTG-S3

    What this source supports

    Supports: Quarter baseline. Reviewed: 15 November 2026, 16:55 SGT (edition-level source review checkpoint; HTTP completion clocks unavailable). Access: Opened/checked through web; date of HTTP retrieval not independently provided.

  4. Source ID

    ENTG-S4

    What this source supports

    Supports: Completed acquisition vs unbuilt line and development. Reviewed: 15 November 2026, 16:55 SGT (edition-level source review checkpoint; HTTP completion clocks unavailable). Access: Opened/checked through web; date of HTTP retrieval not independently provided.

  5. Source ID

    ENTG-S5

    What this source supports

    Supports: Development only, no commercial sale. Reviewed: 15 November 2026, 16:55 SGT (edition-level source review checkpoint; HTTP completion clocks unavailable). Access: Opened/checked through web; date of HTTP retrieval not independently provided.

  6. Source ID

    ENTG-S6

    What this source supports

    Supports: Management targets, not delivered results. Reviewed: 15 November 2026, 16:55 SGT (edition-level source review checkpoint; HTTP completion clocks unavailable). Access: Opened/checked through web; date of HTTP retrieval not independently provided.

  7. Source ID

    ENTG-S7

    What this source supports

    Supports: IP collaboration evidence, not incremental sales. Reviewed: 15 November 2026, 16:55 SGT (edition-level source review checkpoint; HTTP completion clocks unavailable). Access: Opened/checked through web; date of HTTP retrieval not independently provided.

  8. Source ID

    ENTG-S8

    What this source supports

    Supports: Evidence of patent conflict and process competition. Reviewed: 15 November 2026, 16:55 SGT (edition-level source review checkpoint; HTTP completion clocks unavailable). Access: Opened/checked through web; date of HTTP retrieval not independently provided.

  9. Source ID

    ENTG-S9

    What this source supports

    Supports: USD 147.41 Friday close. Reviewed: 15 November 2026, 16:55 SGT (edition-level source review checkpoint; HTTP completion clocks unavailable). Access: Opened/checked through web; date of HTTP retrieval not independently provided.

Source limits

Original source register

Each entry specifies the source and what it can establish. Retrieval checkpoint is a single edition-level check, not a claim to individual upstream HTTP completion clocks. Links are genuine direct URLs but some access remains partial.

1. Third-quarter 2026 financial results | Entegris | source date: 29 Oct 2026 | US / English

https://investor.entegris.com/news/news-details/2026/Entegris-Reports-Results-for-Third-Quarter-of-2026/default.aspx

Supports: Q3 sales, profits and adjustment detail. Reviewed: 15 November 2026, 16:55 SGT (edition-level source review checkpoint; HTTP completion clocks unavailable). Access: Opened/checked through web; date of HTTP retrieval not independently provided.

2. Second-quarter 2026 financial results | Entegris | source date: 4 Aug 2026 | US / English

https://investor.entegris.com/news/news-details/2026/Entegris-Reports-Results-for-Second-Quarter-of-2026/default.aspx

Supports: Earlier quarterly sales trend. Reviewed: 15 November 2026, 16:55 SGT (edition-level source review checkpoint; HTTP completion clocks unavailable). Access: Opened/checked through web; date of HTTP retrieval not independently provided.

3. First-quarter 2026 financial results | Entegris | source date: 30 Apr 2026 | US / English

https://investor.entegris.com/news/news-details/2026/Entegris-Reports-Results-for-First-Quarter-of-2026/default.aspx

Supports: Quarter baseline. Reviewed: 15 November 2026, 16:55 SGT (edition-level source review checkpoint; HTTP completion clocks unavailable). Access: Opened/checked through web; date of HTTP retrieval not independently provided.

4. SiC and diamond thermal-materials expansion | Entegris | source date: 3 Nov 2026 | US / English; Taiwan plan

https://investor.entegris.com/news/news-details/2026/Entegris-Enters-Silicon-Carbide-and-Diamond-Enabled-Thermal-Management-Materials-Market-for-AI-Advanced-Packaging/default.aspx

Supports: Completed acquisition vs unbuilt line and development. Reviewed: 15 November 2026, 16:55 SGT (edition-level source review checkpoint; HTTP completion clocks unavailable). Access: Opened/checked through web; date of HTTP retrieval not independently provided.

5. Kioxia partnership for future memory materials | Entegris | source date: 5 Nov 2026 | US and Japan / English

https://investor.entegris.com/news/news-details/2026/Entegris-Expands-Strategic-Partnership-with-Kioxia-to-Accelerate-Materials-Innovation-for-Next-Generation-Memory-in-the-AI-Era/default.aspx

Supports: Development only, no commercial sale. Reviewed: 15 November 2026, 16:55 SGT (edition-level source review checkpoint; HTTP completion clocks unavailable). Access: Opened/checked through web; date of HTTP retrieval not independently provided.

6. Capital Markets Day long-term model | Entegris | source date: 9 Nov 2026 | US / English

https://investor.entegris.com/news/news-details/2026/Entegris-Details-Growth-Strategy-and-Long-Term-Financial-Model-at-2026-Capital-Markets-Day/default.aspx

Supports: Management targets, not delivered results. Reviewed: 15 November 2026, 16:55 SGT (edition-level source review checkpoint; HTTP completion clocks unavailable). Access: Opened/checked through web; date of HTTP retrieval not independently provided.

7. EUV materials cross-licensing announcement | Entegris and JSR / Inpria | source date: 26 May 2026 | US and Japan / English

https://investor.entegris.com/news/news-details/2026/Entegris-and-JSR-CorporationInpria-Corporation-Announce-Non-Exclusive-Cross-Licensing-to-EUV-Lithography/default.aspx

Supports: IP collaboration evidence, not incremental sales. Reviewed: 15 November 2026, 16:55 SGT (edition-level source review checkpoint; HTTP completion clocks unavailable). Access: Opened/checked through web; date of HTTP retrieval not independently provided.

8. CMP patent portfolio litigation update | Entegris | source date: 18 Aug 2026 | US / English; Asia courts

https://investor.entegris.com/news/news-details/2026/Entegris-Achieves-Further-Success-in-Defending-Its-CMP-Slurry-Patent-Portfolio/default.aspx

Supports: Evidence of patent conflict and process competition. Reviewed: 15 November 2026, 16:55 SGT (edition-level source review checkpoint; HTTP completion clocks unavailable). Access: Opened/checked through web; date of HTTP retrieval not independently provided.

9. ENTG historical closing price | Stock Analysis / S&P Global Market Intelligence | source date: 13 Nov 2026 | US / English

https://stockanalysis.com/stocks/entg/history/

Supports: USD 147.41 Friday close. Reviewed: 15 November 2026, 16:55 SGT (edition-level source review checkpoint; HTTP completion clocks unavailable). Access: Opened/checked through web; date of HTTP retrieval not independently provided.

Back to Signals